» Articles » PMID: 39077616

A Brief Introduction to Management of LQTS

Overview
Date 2024 Jul 30
PMID 39077616
Authors
Affiliations
Soon will be listed here.
Citing Articles

Case report: A 56-year-old woman presenting with torsades de pointes and cardiac arrest associated with levosimendan administration and underlying congenital long QT syndrome type 1.

Zha F, Li X, Yin H, Huang D, Du Y, Zhou C Heliyon. 2024; 10(8):e29300.

PMID: 38644859 PMC: 11033119. DOI: 10.1016/j.heliyon.2024.e29300.

References
1.
Kaufman E, Eckhardt L, Ackerman M, Aziz P, Behr E, Cerrone M . Management of Congenital Long-QT Syndrome: Commentary From the Experts. Circ Arrhythm Electrophysiol. 2021; 14(7):e009726. PMC: 8301722. DOI: 10.1161/CIRCEP.120.009726. View

2.
Pinski S, Eguia L, Trohman R . What is the minimal pacing rate that prevents torsades de pointes? Insights from patients with permanent pacemakers. Pacing Clin Electrophysiol. 2002; 25(11):1612-5. DOI: 10.1046/j.1460-9592.2002.01612.x. View

3.
Cho Y . Left cardiac sympathetic denervation: An important treatment option for patients with hereditary ventricular arrhythmias. J Arrhythm. 2016; 32(5):340-343. PMC: 5063267. DOI: 10.1016/j.joa.2015.08.002. View

4.
Horvath B, Hezso T, Kiss D, Kistamas K, Magyar J, Nanasi P . Late Sodium Current Inhibitors as Potential Antiarrhythmic Agents. Front Pharmacol. 2020; 11:413. PMC: 7184885. DOI: 10.3389/fphar.2020.00413. View

5.
Roden D, Johnson J, Kimmel S, Krauss R, Medina M, Shuldiner A . Cardiovascular pharmacogenomics. Circ Res. 2011; 109(7):807-20. PMC: 3201825. DOI: 10.1161/CIRCRESAHA.110.230995. View